Type IV H2 tanks have started rolling out from FORVIA’s groundbreaking mass production plant in Allenjoie, France. This first-of-its-kind facility in Europe and North America aims to produce 100,000 tanks annually.
With H2 as a driving force behind the decarbonization of mobility and industry, FORVIA is committed to delivering safe and affordable H2 storage technology. By streamlining processes and excelling in industrialization, we will slash production costs by five between 2023 and 2025.
This plant will serve the automotive and H2 distribution and storage industries for the European market. Leading European customers such as Stellantis, Hyvia and MAN have already placed their trust in us to deliver solutions for on-board mobility applications. The plant will also produce the Type IV tanks that make up the large-scale H2 storage solution which will be delivered to AirFlow for distribution & storage application.
“FORVIA has reached a major milestone in its H2 history. With deliveries already underway and a robust order book, our Allenjoie plant sets a new benchmark. From tank manufacturing to complete storage systems, our mid-term capacity of 100,000 tanks per year demonstrates our commitment to mass production and operational excellence. We're driving the safe, affordable H2 technology our society needs, meeting customer expectations and decarbonizing our future,” declared Patrick Koller, CEO of FORVIA.
The plant in Allenjoie symbolizes FORVIA’s unwavering commitment to sustainability. Engineered with sustainability at its core, the plant consumes less energy and has received the prestigious BREEAM Excellent certification in 2022. As the first plant in France and only the second in Europe to achieve this high-level sustainability certification, it serves as a blueprint for the deployment of the FORVIA’s global production standards. Expansion plans in China, North America, and Korea are already in motion, solidifying our commitment to a decarbonized industry.
Since 2018, FORVIA has invested over €380 MM in H2 technology development. We remain steadfast in our commitment to this promising market, which is expected to grow to €20 B in 2030. FORVIA and Symbio have registered a cumulated order intake of €1.2 B aligned with the long-term ambition of FORVIA as a leader in H2 with revenues of €3.5 B in 2030.